Rebel Medicine Inc is a clinical-stage biotechnology company focused on developing innovative drug delivery systems and non-opioid pain therapeutics for acute and post-operative pain. The company is advancing its lead non-opioid pain drug candidate, Alevatrix™, through clinical trials to evaluate its safety and efficacy in managing pain, aiming to provide effective alternatives to opioid treatments.
Rebel Medicine Inc had 15 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Rebel Medicine Inc had 670 followers as of October 12, 2026. The number of followers increased by 1 (0.15%) week-over-week.
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jun 12, 2025 | Series A | $6.00M | ― |
| Investor Name | Funding Round |
|---|---|
| Crocker Ventures | Series A |
| Central Texas Angel Network | Series A |
| Prosperity Solutions Capital | Series A |
| Utah Innovation Fund | Series A |
| SK Hart | Series A |
| the Joan & Tim Fenton Fund | Series A |
| Cantina Angels | Series A |
A snapshot of private companies similar to Rebel Medicine Inc, helping you discover and navigate related company profiles.



